Development of Conformationally Restricted Negamycin Derivatives for Potent Readthrough Activity.
Omura N, Taguchi A, Kuwahara T, Hamada K, Watanabe M, Nakakuki M, Konno S, Takayama K, Taniguchi A, Nomura T, Shuto S, Hayashi Y.
Omura N, et al. Among authors: nakakuki m.
ACS Med Chem Lett. 2023 Dec 4;14(12):1807-1814. doi: 10.1021/acsmedchemlett.3c00424. eCollection 2023 Dec 14.
ACS Med Chem Lett. 2023.
PMID: 38116427
Free PMC article.